An in-vitro study of antifungal activity of gymnemic acid
dc.contributor.advisor | Holmes, Haly | |
dc.contributor.author | Asmyou, Sana Alhadi | |
dc.date.accessioned | 2018-08-13T07:47:03Z | |
dc.date.accessioned | 2024-04-16T13:23:39Z | |
dc.date.available | 2018-08-31T22:10:06Z | |
dc.date.available | 2024-04-16T13:23:39Z | |
dc.date.issued | 2017 | |
dc.description | Magister Chirurgiae Dentium - MChD (Oral Medicine and Periodontics) | |
dc.description.abstract | Candida species are frequently isolated from oral mucosal surfaces of healthy individuals and is the most common genus responsible for up to 75% of all candidal infections. The most common problems associated management of oral candidiasis are antifungal drug resistance and side effects Natural medicine is an emerging field and is being explored to overcome drug resistance and to reduce side effects. Gymnemagenin (will be known as Gymnemic acid; GA) is a purified extract from Gymnema sylvestre, a slow growing, perennial, medicinal plant found in Central and Western India, Tropical Africa and Australia is regarded as one of the plants with potent antimicrobial and antifungal activity. | |
dc.identifier.uri | https://hdl.handle.net/10566/11037 | |
dc.language.iso | en | |
dc.publisher | University of the Western Cape | |
dc.rights.holder | University of the Western Cape | |
dc.subject | Gymnemic acid, Chlorhexidine gluconate, Nystatin, Candida Spp, Inhibition zone, Bud size, Hyphae length, Antifungal activity | |
dc.title | An in-vitro study of antifungal activity of gymnemic acid |
Files
Original bundle
1 - 1 of 1